Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer

NCT06149767 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

26

Enrollment

OTHER_GOV

Sponsor class

Conditions

Cervical Cancer

Interventions

DRUG: Adebrelimab

Sponsor

Fujian Cancer Hospital